论文信息 - The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study - 字舞流文

The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study

P. Queirolo | M. Del Vecchio | V. Chiarion Sileni | G. Rinaldi | T. Troiani | A. Minisini | P. Quaglino | R. Depenni | E. Rossi | F. Consoli | M. Banzi | F. Carnevale-Schianca | A. Sponghini | R. Marconcini | M. F. Morelli | I. Marcon | D. Palleschi | Roberta Depenni | Vanna Chiarion Sileni | Gaetana Rinaldi | Alessandro Minisini | Teresa Troiani | Francesca Consoli | Andrea Sponghini | Maria Francesca Morelli | Dario Palleschi | Riccardo Marconcini | Fabrizio Carnevale-Schianca | Ilaria Marcon